Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 25Neoplasm Metastasis 6Metastatic Hormone-sensitive Prostate Cancer 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Stage I Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Recurrence 1Non-metastatic, Hormone naïve Prostate Cancer 1Neoplasms 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Lymphatic Metastasis 1Insulin Resistance 1Adenocarcinoma of the Prostate 1

Interventions

sipuleucel-T 1pazopanib 1enzalutamide 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma of the Prostate × Androgen Antagonists × Clear all
NCT01517451 2026-02-11

Radiation and Androgen Ablation for Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
45 enrolled 11 charts
Genitourinary

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡